Incyte Supports the Myeloproliferative Neoplasm (MPN) Community During Blood Cancer Awareness Month
- New resources are now available to help patients track their disease and activate the community to increase awareness of rare blood cancers
- Facebook Live Q&A to be held on MPN Awareness Day,
September 14, 2017 , from7:00-8:00 p.m. ET
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170901005139/en/
To support the MPN community,
“The cancer journey is full of challenges. For patients living with a rare cancer that may be unfamiliar to their doctors or families, it can be especially difficult. Along with our work to discover and develop new medicines to treat cancer,
MPN Awareness Resources Now Available Include:
- MPN IQ Quiz: The MPN IQ Quiz allows users to test their MPN knowledge and challenge others to test their own MPN IQ.
- PV Tracker Tool: Visit this digital PV Tracker Tool designed to help track PV symptoms, blood cell counts, and phlebotomy appointments.
- MPN Awareness Social Media Photo Filter: Show support and raise awareness of MPNs by visiting http://mpnawareness.twibbon.com/ and adding an MPN Awareness photo filter to a
Facebook or Twitter profile picture.
“Patients with progressive diseases face difficulty when it comes to recognizing and tracking changes in their symptoms. Communicating with your physician when you are experiencing symptom abnormalities is critical to taking care of yourself as a patient,” said
To further help answer questions related to MPNs,
Stay connected and informed about all of the MPN awareness activities by “Liking” the “Voices of MPN”
About Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are a closely related group of blood cancers in which the bone marrow functions abnormally.i The bone marrow is where the body’s blood cells are made. The three main myeloproliferative neoplasms are myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET).i MPNs are progressive blood cancers that can strike anyone at any age, but they are more common in older adults. Estimates of the prevalence of MPNs vary, but analysis of claims data suggests there may be as many as 200,000 people in the U.S. living with MF, PV or ET.ii
About
Follow @
References
i Understanding MPNs.
ii Data on File.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170901005139/en/
Source:
For Incyte Corporation:
Jenifer Antonacci, 302-498-7036
jantonacci@incyte.com
or
Elliot Fox, 212-257-6724
efox@w2ogroup.com
or
Catalina Loveman, 302-498-6171
cloveman@incyte.com